Application

LUMAKRAS

Amgen Inc.

Trademark/Service Mark Application, Principal Register

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)

Trademark/Service Mark Application, Principal Register

Serial Number: 90044720
Filing Date: 07/09/2020

The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 90044720
MARK INFORMATION
*MARK LUMAKRAS
STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
LITERAL ELEMENT LUMAKRAS
MARK STATEMENT The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER Principal
APPLICANT INFORMATION
*OWNER OF MARK Amgen Inc.
INTERNAL ADDRESS Trademark Operations - MS-28-5A
*MAILING ADDRESS One Amgen Center Drive
*CITY Thousand Oaks
*STATE
(Required for U.S. applicants)
California
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
91320-1799
PHONE 804-447-3278
*EMAIL ADDRESS XXXX
WEBSITE ADDRESS www.amgen.com
LEGAL ENTITY INFORMATION
TYPE corporation
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF INCORPORATION Delaware
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS 005 
*IDENTIFICATION Pharmaceutical preparations; pharmaceutical preparations for use in the treatment of cancer, oncology, tumors, solid and hematological tumors and growths, hematological and hemolytic diseases and disorders, including bone, joint, vertebral column, intestine, colon, skin, lung, eye, breast, ovary, cervix, stomach, bladder, kidney, head, brain, neck, and blood diseases and disorders; amyloidosis, metabolic diseases and disorders, lupus, and inflammation and autoimmune diseases and disorders; pharmaceutical preparations for use in the treatment of solid tumors and growths, hemolytic diseases and disorders, amylodiosis, metabolic diseases and disorders, lupus, and inflammation and autoimmune diseases and disorders
FILING BASIS SECTION 1(b)
ATTORNEY INFORMATION
NAME Elsa D. Lemoine
ATTORNEY DOCKET NUMBER TM-2089-US-1
ATTORNEY BAR MEMBERSHIP NUMBER XXX
YEAR OF ADMISSION XXXX
U.S. STATE/ COMMONWEALTH/ TERRITORY XX
FIRM NAME Amgen Inc.
INTERNAL ADDRESS Trademark Operations-MS-28-5A
STREET One Amgen Center Drive
CITY Thousand Oaks
STATE California
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
ZIP/POSTAL CODE 91320-1799
PHONE 805-447-3278
EMAIL ADDRESS elemoine@amgen.com
OTHER APPOINTED ATTORNEY Timothy J. Gaul, Richard V. Person, and Stuart L. Watt
CORRESPONDENCE INFORMATION
NAME Elsa D. Lemoine
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE elemoine@amgen.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) tmops@amgen.com
FEE INFORMATION
APPLICATION FILING OPTION TEAS Standard
NUMBER OF CLASSES 1
APPLICATION FOR REGISTRATION PER CLASS 275
*TOTAL FEES DUE 275
*TOTAL FEES PAID 275
SIGNATURE INFORMATION
SIGNATURE /Elsa D. Lemoine/
SIGNATORY'S NAME Lemoine, Elsa D.
SIGNATORY'S POSITION Attorney of Record, California Bar member
SIGNATORY'S PHONE NUMBER 805-447-3278
DATE SIGNED 07/09/2020



Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)


Trademark/Service Mark Application, Principal Register

Serial Number: 90044720
Filing Date: 07/09/2020

To the Commissioner for Trademarks:

MARK: LUMAKRAS (Standard Characters, see mark)
The literal element of the mark consists of LUMAKRAS. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, Amgen Inc., a corporation of Delaware, having an address of
      Trademark Operations - MS-28-5A
      One Amgen Center Drive
      Thousand Oaks, California 91320-1799
      United States
      804-447-3278(phone)
      XXXX

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

International Class 005:  Pharmaceutical preparations; pharmaceutical preparations for use in the treatment of cancer, oncology, tumors, solid and hematological tumors and growths, hematological and hemolytic diseases and disorders, including bone, joint, vertebral column, intestine, colon, skin, lung, eye, breast, ovary, cervix, stomach, bladder, kidney, head, brain, neck, and blood diseases and disorders; amyloidosis, metabolic diseases and disorders, lupus, and inflammation and autoimmune diseases and disorders; pharmaceutical preparations for use in the treatment of solid tumors and growths, hemolytic diseases and disorders, amylodiosis, metabolic diseases and disorders, lupus, and inflammation and autoimmune diseases and disorders
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.



For informational purposes only, applicant's website address is: www.amgen.com

The owner's/holder's proposed attorney information: Elsa D. Lemoine. Other appointed attorneys are Timothy J. Gaul, Richard V. Person, and Stuart L. Watt. Elsa D. Lemoine of Amgen Inc., is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, and the attorney(s) is located at
      Trademark Operations-MS-28-5A
      One Amgen Center Drive
      Thousand Oaks, California 91320-1799
      United States
      805-447-3278(phone)
      elemoine@amgen.com
The docket/reference number is TM-2089-US-1.
Elsa D. Lemoine submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S. Commonwealth or territory.
The applicant's current Correspondence Information:
      Elsa D. Lemoine
       PRIMARY EMAIL FOR CORRESPONDENCE: elemoine@amgen.com
       SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): tmops@amgen.com


Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $275 has been submitted with the application, representing payment for 1 class(es).

Declaration

Declaration Signature

Signature: /Elsa D. Lemoine/   Date: 07/09/2020
Signatory's Name: Lemoine, Elsa D.
Signatory's Position: Attorney of Record, California Bar member
Payment Sale Number: 90044720
Payment Accounting Date: 07/09/2020

Serial Number: 90044720
Internet Transmission Date: Thu Jul 09 17:36:38 ET 2020
TEAS Stamp: USPTO/BAS-XXX.XXX.XXX.XXX-20200709173638
279652-90044720-710f14a8105c3576b494ce72
29a4cf1a6e12cd14caab2d7bed17981fab9b9e81
10-DA-36376131-20200709153919684862

Application [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed